Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Drones deliver AEDs in US | European study finds cost savings of early TAVR in asymptomatic AS | Flurpiridaz sees rapid growth
Thursday, November 20, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Drones deliver AEDs for the first time in the United States

“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."

READ MORE >
Duke University is heading a project that for the first time in the United States, drones will be used to quickly deliver automated external defibrillators (AEDs) to bystanders who call 911 for patients in cardiac arrest. The idea is to deliver an AED faster than police or paramedics could arrive on scene, saving critical minutes in an effort to boost survival.
Share on Twitter Share on Facebook Share on Linkedin

Drones deliver AEDs for the first time in the United States

Share on Twitter Share on Facebook Share on Linkedin
Duke University is heading a project that for the first time in the United States, drones will be used to quickly deliver automated external defibrillators (AEDs) to bystanders who call 911 for patients in cardiac arrest. The idea is to deliver an AED faster than police or paramedics could arrive on scene, saving critical minutes in an effort to boost survival.
“This study represents a major step forward in how we respond to cardiac arrest in the United States,” explained Monique Starks, MD, principal investigator. “By integrating drone technology into emergency care, we’re working to close the critical gap between cardiac arrest and treatment."
READ MORE >

Early TAVR for asymptomatic severe AS cuts costs, improves outcomes

The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.

READ MORE >
Edwards Lifesciences Sapien 3 TAVR valves at TCT 2024 DF 1
Share on Twitter Share on Facebook Share on Linkedin

Early TAVR for asymptomatic severe AS cuts costs, improves outcomes

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences Sapien 3 TAVR valves at TCT 2024 DF 1
The study found lifetime per-patient savings from early TAVR ranged from about $2,334 in the U.K. to $19,607 in Switzerland.
READ MORE >

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.

READ MORE >
The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.
Share on Twitter Share on Facebook Share on Linkedin

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

Share on Twitter Share on Facebook Share on Linkedin
The new cardiac PET radiotracer flurpiridaz F-18 is posed to be a major game changer and will likely lead to increased adoption of cardiac PET.
One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.
READ MORE >

Featured Articles

Winning cash for taking blood pressure meds increases compliance

About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Winning cash for taking blood pressure meds increases compliance

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.
READ MORE >

SCAI: Noncompete contracts unfairly bind cardiologists to hospitals unless they move

"These provisions are contained in what amounts, in many cases, to contracts of adhesion, because a physician’s only choice is to accept the terms of the contract without revision or else forgo employment," the Society for Cardiovascular Angiography and Interventions wrote to the U.S. Federal Trade Commission.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

SCAI: Noncompete contracts unfairly bind cardiologists to hospitals unless they move

Share on Twitter Share on Facebook Share on Linkedin
"These provisions are contained in what amounts, in many cases, to contracts of adhesion, because a physician’s only choice is to accept the terms of the contract without revision or else forgo employment," the Society for Cardiovascular Angiography and Interventions wrote to the U.S. Federal Trade Commission.
READ MORE >

Device to treat coronary microvascular disease rakes in $23 million in financing

With no treatments available that directly improve INOCA, this breakthrough device offers hope.

READ MORE >
VahatiCor's investigational A-Flux Reducer System helps increase perfusion by restricting the venous flow in the coronary sinus.
Share on Twitter Share on Facebook Share on Linkedin

Device to treat coronary microvascular disease rakes in $23 million in financing

Share on Twitter Share on Facebook Share on Linkedin
VahatiCor's investigational A-Flux Reducer System helps increase perfusion by restricting the venous flow in the coronary sinus.
With no treatments available that directly improve INOCA, this breakthrough device offers hope.
READ MORE >

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial

The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.

READ MORE >
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Share on Twitter Share on Facebook Share on Linkedin

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial

Share on Twitter Share on Facebook Share on Linkedin
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.
READ MORE >

U.S. International Federal Trade Commission reviews ban on new Apple Watch pulse oximeter

Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.

READ MORE >
Apple has officially introduced the Apple Watch Ultra 3, which will provide notifications when it detects signs of chronic high blood pressure once the technology is cleared by the U.S. Food and Drug Administration (FDA).
Share on Twitter Share on Facebook Share on Linkedin

U.S. International Federal Trade Commission reviews ban on new Apple Watch pulse oximeter

Share on Twitter Share on Facebook Share on Linkedin
Apple has officially introduced the Apple Watch Ultra 3, which will provide notifications when it detects signs of chronic high blood pressure once the technology is cleared by the U.S. Food and Drug Administration (FDA).
Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.
READ MORE >

In Other News

Radiology societies join initiative to fight payer restrictions around key interventional service

ACR, SIR and others altogether representing over 100,000 physicians recently wrote to 5 of the 7 Medicare Administrative Contractors to voice their concerns. 

READ MORE >
money maze payment reimbursement
Share on Twitter Share on Facebook Share on Linkedin

Radiology societies join initiative to fight payer restrictions around key interventional service

Share on Twitter Share on Facebook Share on Linkedin
money maze payment reimbursement
ACR, SIR and others altogether representing over 100,000 physicians recently wrote to 5 of the 7 Medicare Administrative Contractors to voice their concerns. 
READ MORE >

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman. 

READ MORE >
UCLA Health
Share on Twitter Share on Facebook Share on Linkedin

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

Share on Twitter Share on Facebook Share on Linkedin
UCLA Health
“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman. 
READ MORE >

FDA clears RapidAI's opportunistic aortic management tool

The solution can assess the aorta on any CT scan that offers visualization of it, including post-treatment and unenhanced noncontrast studies. 

READ MORE >
RapidAI's opportunistic aortic management tool earns FDA clearance
Share on Twitter Share on Facebook Share on Linkedin

FDA clears RapidAI's opportunistic aortic management tool

Share on Twitter Share on Facebook Share on Linkedin
RapidAI's opportunistic aortic management tool earns FDA clearance
The solution can assess the aorta on any CT scan that offers visualization of it, including post-treatment and unenhanced noncontrast studies. 
READ MORE >

Cigna announces new copay-centric insurance model, backed by AI care coordination

Dubbed “Clearity,” the new health plans will have four tiers to choose from, allowing patients to select the provider and services that are right for them. The insurance is similar to a concierge care model, but backed by a potentially larger network.

READ MORE >
Cigna, one of the nation’s largest health insurance providers, announced new priorities for its capital deployment, including steering an additional $450 million into Cigna Ventures.
Share on Twitter Share on Facebook Share on Linkedin

Cigna announces new copay-centric insurance model, backed by AI care coordination

Share on Twitter Share on Facebook Share on Linkedin
Cigna, one of the nation’s largest health insurance providers, announced new priorities for its capital deployment, including steering an additional $450 million into Cigna Ventures.
Dubbed “Clearity,” the new health plans will have four tiers to choose from, allowing patients to select the provider and services that are right for them. The insurance is similar to a concierge care model, but backed by a potentially larger network.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup